|
|
Trade Name |
: |
IMACEF 1 GM IM |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
|
|
Trade Name |
: |
IMACEF 1 GM IV |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
|
|
Trade Name |
: |
Imacef 2 g IV |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef 2 g IV: Each vial contains Ceftriaxone 2 g (as sterile Ceftriaxone Sodium USP). |
|
|
| |
|
|
Trade Name |
: |
IMACEF 250 GM IM |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
|
|
Trade Name |
: |
IMACEF 250 GM IV |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
|
|
Trade Name |
: |
IMACEF 500 GM IM |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
|
|
Trade Name |
: |
IMACEF 500 GM IV |
| Generic Name |
: |
Ceftriaxone |
| Description |
: |
Imacef is indicated for the treatment of the following infections when caused by susceptible organisms:
Lower Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus, |
|
|
| |
